Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

MUC2 and MUC6 apomucins expression in human gastric neoplasm: an immunohistochemical analysis.

Khattab AZ, Nasif WA, Lotfy M.

Med Oncol. 2011 Dec;28 Suppl 1:S207-13. doi: 10.1007/s12032-010-9699-5. Epub 2010 Sep 29.

PMID:
20878553
3.

Immunohistochemical study of the expression of MUC6 mucin and co-expression of other secreted mucins (MUC5AC and MUC2) in human gastric carcinomas.

Reis CA, David L, Carvalho F, Mandel U, de Bolós C, Mirgorodskaya E, Clausen H, Sobrinho-Simões M.

J Histochem Cytochem. 2000 Mar;48(3):377-88.

PMID:
10681391
4.
5.

Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression.

Reis CA, David L, Correa P, Carneiro F, de Bolós C, Garcia E, Mandel U, Clausen H, Sobrinho-Simões M.

Cancer Res. 1999 Mar 1;59(5):1003-7.

6.

The relationship among PDX1, CDX2, and mucin profiles in gastric carcinomas; correlations with clinicopathologic parameters.

Oz Puyan F, Can N, Ozyilmaz F, Usta U, Sut N, Tastekin E, Altaner S.

J Cancer Res Clin Oncol. 2011 Dec;137(12):1749-62. doi: 10.1007/s00432-011-1044-7. Epub 2011 Sep 10.

PMID:
21909647
7.

Aberrant expression of the gastric mucin MUC6 in human pulmonary adenocarcinoma xenografts.

Hamamoto A, Abe Y, Nishi M, Fujimori S, Ohnishi Y, Yamazaki H, Oida Y, Miyazaki N, Inada K, Ueyama Y, Iwasaki M, Inoue H, Nakamura M.

Int J Oncol. 2005 Apr;26(4):891-6.

PMID:
15753982
8.

Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impact.

Park SY, Roh SJ, Kim YN, Kim SZ, Park HS, Jang KY, Chung MJ, Kang MJ, Lee DG, Moon WS.

Oncol Rep. 2009 Sep;22(3):649-57.

PMID:
19639217
9.

Gastric and intestinal phenotypic cell marker expressions in gastric differentiated-type carcinomas: association with E-cadherin expression and chromosomal changes.

Morohara K, Tajima Y, Nakao K, Nishino N, Aoki S, Kato M, Sakamoto M, Yamazaki K, Kaetsu T, Suzuki S, Tsunoda A, Tachikawa T, Kusano M.

J Cancer Res Clin Oncol. 2006 Jun;132(6):363-75. Epub 2006 Jan 31.

PMID:
16447040
10.

Expression of MUC2, MUC5AC and MUC6 apomucins in carcinoma, dysplasia and non-dysplastic epithelia of the gallbladder.

Sasaki M, Yamato T, Nakanuma Y, Ho SB, Kim YS.

Pathol Int. 1999 Jan;49(1):38-44.

PMID:
10227723
11.

Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma.

Pinto-de-Sousa J, David L, Reis CA, Gomes R, Silva L, Pimenta A.

Virchows Arch. 2002 Mar;440(3):304-10. Epub 2001 Oct 23.

PMID:
11889602
12.

Immunohistochemical Expressions of MUC2, MUC5AC, and MUC6 in Normal, Helicobacter pylori Infected and Metaplastic Gastric Mucosa of Children and Adolescents.

Park JS, Yeom JS, Seo JH, Lim JY, Park CH, Woo HO, Youn HS, Jun JS, Park JH, Ko GH, Baik SC, Lee WK, Cho MJ, Rhee KH.

Helicobacter. 2015 Aug;20(4):260-8. doi: 10.1111/hel.12198. Epub 2015 Feb 23.

PMID:
25704078
13.

MUC6 down-regulation correlates with gastric carcinoma progression and a poor prognosis: an immunohistochemical study with tissue microarrays.

Zheng H, Takahashi H, Nakajima T, Murai Y, Cui Z, Nomoto K, Tsuneyama K, Takano Y.

J Cancer Res Clin Oncol. 2006 Dec;132(12):817-23. Epub 2006 Jun 29.

PMID:
16807756
14.

MUC5B expression in gastric carcinoma: relationship with clinico-pathological parameters and with expression of mucins MUC1, MUC2, MUC5AC and MUC6.

Pinto-de-Sousa J, Reis CA, David L, Pimenta A, Cardoso-de-Oliveira M.

Virchows Arch. 2004 Mar;444(3):224-30. Epub 2004 Jan 31.

PMID:
14758553
15.

Phenotype analysis by MUC2, MUC5AC, MUC6, and CD10 expression in Epstein-Barr virus-associated gastric carcinoma.

Barua RR, Uozaki H, Chong JM, Ushiku T, Hino R, Chang MS, Nagai H, Fukayama M.

J Gastroenterol. 2006 Aug;41(8):733-9.

PMID:
16988760
16.

Cadherin-catenin adhesion system and mucin expression: a comparison between young and older patients with gastric carcinoma.

Silva EM, Begnami MD, Fregnani JH, Pelosof AG, Zitron C, Montagnini AL, Soares FA.

Gastric Cancer. 2008;11(3):149-59. doi: 10.1007/s10120-008-0468-5. Epub 2008 Sep 30.

PMID:
18825309
17.

Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma.

Matsukita S, Nomoto M, Kitajima S, Tanaka S, Goto M, Irimura T, Kim YS, Sato E, Yonezawa S.

Histopathology. 2003 Jan;42(1):26-36.

PMID:
12493022
18.

Re-evaluation of phenotypic expression in undifferentiated-type early gastric adenocarcinomas using mucin core protein and CDX2.

Ikarashi S, Nishikura K, Ajioka Y, Aoyagi Y.

Gastric Cancer. 2013 Apr;16(2):208-19. doi: 10.1007/s10120-012-0172-3. Epub 2012 Jul 25.

PMID:
22829163
19.

Re-evaluation of mucin phenotypes of gastric minute well-differentiated-type adenocarcinomas using a series of HGM, MUC5AC, MUC6, M-GGMC, MUC2 and CD10 stains.

Shiroshita H, Watanabe H, Ajioka Y, Watanabe G, Nishikura K, Kitano S.

Pathol Int. 2004 May;54(5):311-21.

PMID:
15086835
20.

Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients.

Utsunomiya T, Yonezawa S, Sakamoto H, Kitamura H, Hokita S, Aiko T, Tanaka S, Irimura T, Kim YS, Sato E.

Clin Cancer Res. 1998 Nov;4(11):2605-14.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk